Iodide

Iodide

SCHEMBL4248459

CSC1=NCCCC1.I

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7395015 0.97
SCHEMBL9380314 0.95 NOS3 (0.42)
Iodomethane SCHEMBL9434948 0.91 NOS3 (0.39)
SCHEMBL1669865 0.90
SCHEMBL16385785 0.65 KMT2A (0.36)
SCHEMBL9056680 0.64
SCHEMBL4280209 0.61
Iodide SCHEMBL2889536 0.61 NISCH (0.39)
Hydrochloric Acid SCHEMBL8323256 0.60
SCHEMBL24971583 0.60 NOS3 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4560758-A IMMUNOMODULATORS PENNWALT CORPORATION (US) 1985-12-24 US claimed
US-20090170844-A1 Spiro Tetracyclic Compound MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2009-07-02 US disclosed
EP-2020411-A1 SPIRO TETRACYCLIC COMPOUND MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2009-02-04 EP disclosed
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE &amp; CO. (US) 1998-02-04 EP disclosed
EP-0150255-B1 Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine immunomodulators FISONS CORPORATION (US) 1990-12-12 EP disclosed
US-4603206-A ALCOHOLS, ETHERS FROM MERCAPTANS, SULFIDES;POSITIVE HALOGENATING AGENT; ALCOHOL; IMMUNOMODULATORS PENNWALT CORPORATION (US) 1986-07-29 US disclosed
US-4560758-A IMMUNOMODULATORS PENNWALT CORPORATION (US) 1985-12-24 US disclosed
US-4551535-A SULFIDING IN THE PRESENCE OF A BASE PENNWALT CORPORATION (US) 1985-11-05 US disclosed
US-4550169-A ANTITUMOR AND ANTICARCINOGENIC AGENTS AMERICAN CYANAMID COMPANY (US) 1985-10-29 US disclosed
EP-0150255-A2 Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine immunomodulators FISONS CORPORATION (US) 1985-08-07 EP disclosed
EP-0146711-A2 2-hydrazino-1H-imidazoles AMERICAN CYANAMID COMPANY (US) 1985-07-03 EP disclosed
US-4507481-A IMMUNOMODULATORS PENNWALT CORPORATION (US) 1985-03-26 US disclosed